BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Yilong Dong, Yang Liu, Aimei Jiang, Ruiqian Li, Min Yin, Yanmei Wang. MicroRNA-335 suppresses the proliferation, migration, and invasion of breast cancer cells by targeting EphA4Molecular and Cellular Biochemistry 2018; 439(1-2): 95 doi: 10.1007/s11010-017-3139-1
2
Yuejun Sun, Jianzhong Qian, Min Lu, Hongming Xu. Lower and reduced expression of EphA4 is associated with advanced TNM stage, lymph node metastasis, and poor survival in breast carcinomaPathology International 2016; 66(9): 506 doi: 10.1111/pin.12444
3
Takuma Yamashita, Kiyohito Kato, Shintaro Fujihara, Hisakazu Iwama, Asahiro Morishita, Hiroki Yamana, Kiyoyuki Kobayashi, Hideki Kamada, Taiga Chiyo, Hideki Kobara, Kunihiko Tsutsui, Keiichi Okano, Yasuyuki Suzuki, Tsutomu Masaki. Anti-diabetic drug metformin inhibits cell proliferation and tumor growth in gallbladder cancer via G0/G1 cell cycle arrestAnti-Cancer Drugs 2020; 31(3): 231 doi: 10.1097/CAD.0000000000000870
4
Su-Hsi Lu, Yu-Ling Chen, Chia-Tung Shun, Jung-Nien Lai, Shian-Yang Peng, Po-Lin Lai, Hey-Chi Hsu. Expression and prognostic significance of gastric-specific annexin A10 in diffuse- and intestinal-type gastric carcinomaJournal of Gastroenterology and Hepatology 2011; 26(1): 90 doi: 10.1111/j.1440-1746.2010.06480.x
5
Jean Defourny, Christiane Peuckert, Klas Kullander, Brigitte Malgrange. EphA4-ADAM10 Interplay Patterns the Cochlear Sensory Epithelium through Local Disruption of Adherens JunctionsiScience 2019; 11: 246 doi: 10.1016/j.isci.2018.12.017
6
Oscar J Buckens, Btissame El Hassouni, Elisa Giovannetti, Godefridus J Peters. The role of Eph receptors in cancer and how to target them: novel approaches in cancer treatmentExpert Opinion on Investigational Drugs 2020; 29(6): 567 doi: 10.1080/13543784.2020.1762566
7
Shintaro Uchiyama, Noritaka Saeki, Kazushige Ogawa. Aberrant EphB/ephrin-B expression in experimental gastric lesions and tumor cellsWorld Journal of Gastroenterology 2015; 21(2): 453-464 doi: 10.3748/wjg.v21.i2.453
8
Kohji Miyazaki, Mikito Inokuchi, Yoko Takagi, Keiji Kato, Kazuyuki Kojima, Kenichi Sugihara. EphA4 is a prognostic factor in gastric cancerBMC Clinical Pathology 2013; 13(1) doi: 10.1186/1472-6890-13-19
9
L. Rhoda Molife, Emma Jane Dean, Montserrat Blanco-Codesido, Matthew G. Krebs, Andre T. Brunetto, Alastair Peter Greystoke, Gennaro Daniele, Lucy Lee, Galina Kuznetsov, Khin Than Myint, Karen Wood, Begoña de las Heras, Malcolm Richard Ranson. A Phase I, Dose-Escalation Study of the Multitargeted Receptor Tyrosine Kinase Inhibitor, Golvatinib, in Patients with Advanced Solid TumorsClinical Cancer Research 2014; 20(24): 6284 doi: 10.1158/1078-0432.CCR-14-0409
10
Jia Chen, Xianming Zhang, Samantha Schaller, Theodore S. Jardetzky, Richard Longnecker, Thomas Shenk. Ephrin Receptor A4 is a New Kaposi’s Sarcoma-Associated Herpesvirus Virus Entry ReceptormBio 2019; 10(1) doi: 10.1128/mBio.02892-18
11
Julia E. Herrmann, Morgan A. Pence, Emanuel A. Shapera, Ravi R. Shah, Cédric G. Geoffroy, Binhai Zheng. Generation of an EphA4 conditional allele in micegenesis 2009; : 1 doi: 10.1002/dvg.20587
12
Oscar P.J. van Linden, Carine Farenc, Willem H. Zoutman, Liesbeth Hameetman, Maikel Wijtmans, Rob Leurs, Cornelis P. Tensen, Gregg Siegal, Iwan J.P. de Esch. Fragment based lead discovery of small molecule inhibitors for the EPHA4 receptor tyrosine kinaseEuropean Journal of Medicinal Chemistry 2012; 47: 493 doi: 10.1016/j.ejmech.2011.11.020
13
Ke Wang, Xin-hui Zhao, Jun Liu, Rui Zhang, Ji-peng Li. Nervous system and gastric cancerBiochimica et Biophysica Acta (BBA) - Reviews on Cancer 2020; 1873(1): 188313 doi: 10.1016/j.bbcan.2019.188313
14
Andrew W. Boyd, Perry F. Bartlett, Martin Lackmann. Therapeutic targeting of EPH receptors and their ligandsNature Reviews Drug Discovery 2014; 13(1): 39 doi: 10.1038/nrd4175
15
Michael P Bova, Gene G Kinney. Emerging drug targets in amyotrophic lateral sclerosisExpert Opinion on Orphan Drugs 2013; 1(1): 5 doi: 10.1517/21678707.2013.744949
16
S. A. Zozulya, I. P. Udovichenko. Eph family receptors as therapeutic targetsRussian Journal of Bioorganic Chemistry 2012; 38(3): 231 doi: 10.1134/S106816201203017X
17
Michael P Bova, Gene G Kinney. Emerging drug targets in amyotrophic lateral sclerosisExpert Opinion on Orphan Drugs 2013; 1(1): 5 doi: 10.1517/21678707.2013.744949
18
CHENGLI LIU, HUI HUANG, CHENG WANG, YALIN KONG, HONGYI ZHANG. Involvement of ephrin receptor A4 in pancreatic cancer cell motility and invasionOncology Letters 2014; 7(6): 2165 doi: 10.3892/ol.2014.2011
19
Liesbeth Hameetman, Leslie van der Fits, Willem H. Zoutman, Jacoba J. Out-Luiting, Gregg Siegal, Iwan J.P. de Esch, Maarten H. Vermeer, Cornelis P. Tensen. EPHA4 is overexpressed but not functionally active in Sézary syndromeOncotarget 2015; 6(31): 31868 doi: 10.18632/oncotarget.5573
20
Ilaria Lamberto, Haina Qin, Roberta Noberini, Lakshmanane Premkumar, Caroline Bourgin, Stefan J. Riedl, Jianxing Song, Elena B. Pasquale. Distinctive binding of three antagonistic peptides to the ephrin-binding pocket of the EphA4 receptorBiochemical Journal 2012; 445(1): 47 doi: 10.1042/BJ20120408
21
Emily J. Cabourne, Gretta Roberts, Robert Goldin, Timothy Ryder, Margaret Mobberly, Paul Ziprin. Investigation of Tumor–Peritoneal Interactions in the Pathogenesis of Peritoneal Metastases using a Novel Ex Vivo Peritoneal Model1Journal of Surgical Research 2010; 164(2): e265 doi: 10.1016/j.jss.2010.09.041
22
Thomas Gaitanos, Irina Dudanova, Maria Sakkou, Rüdiger Klein, Sónia Paixão. Receptor Tyrosine Kinases: Family and Subfamilies2015; : 165 doi: 10.1007/978-3-319-11888-8_5
23
Stamatios Theocharis, Jerzy Klijanienko, Constantinos Giaginis, Paraskevi Alexandrou, Efstratios Patsouris, Xavier Sastre-Garau. Ephrin Receptor (Eph) -A1, -A2, -A4 and -A7 Expression in Mobile Tongue Squamous Cell Carcinoma: Associations with Clinicopathological Parameters and Patients SurvivalPathology & Oncology Research 2014; 20(2): 277 doi: 10.1007/s12253-013-9692-3
24
Chaochao Xu, Wulan Li, Peihong Qiu, Yiqun Xia, Xiaojing Du, Fen Wang, Lailai Shen, Qiuxiang Chen, Yunjie Zhao, Rong Jin, Jianzhang Wu, Guang Liang, Xiaokun Li. The therapeutic potential of a novel non-ATP-competitive fibroblast growth factor receptor 1 inhibitor on gastric cancerAnti-Cancer Drugs 2015; 26(4): 379 doi: 10.1097/CAD.0000000000000195
25
E. S. Grigorieva, Yu. A. Bukurova, G. S. Krasnov, S. G. Afanas’ev, N. V. Cherdyntseva, S. A. Tuzikov, E. L. Choinzonov, V. L. Karpov, N. A. Lisitsyn, S. F. Beresten. Identification of proteins overexpressed in malignant gastric tumors: Comparison of results obtained by 2DE and bioinformatic searchMolecular Biology 2011; 45(4): 680 doi: 10.1134/S0026893311030058
26
Xiaofeng Han, Yan Xu, Yilei Yang, Jingle Xi, Wang Tian, Srinivas Duggineni, Ziwei Huang, Jing An, Jie Zheng. Discovery and Characterization of a Novel Cyclic Peptide That Effectively Inhibits Ephrin Binding to the EphA4 Receptor and Displays Anti-Angiogenesis ActivityPLoS ONE 2013; 8(11): e80183 doi: 10.1371/journal.pone.0080183
27
Haihui Lu, Karl R. Clauser, Wai Leong Tam, Julia Fröse, Xin Ye, Elinor Ng Eaton, Ferenc Reinhardt, Vera S. Donnenberg, Rohit Bhargava, Steven A. Carr, Robert A. Weinberg. A breast cancer stem cell niche supported by juxtacrine signalling from monocytes and macrophagesNature Cell Biology 2014; 16(11): 1105 doi: 10.1038/ncb3041
28
HIDEAKI MURASE, MIKITO INOKUCHI, YOKO TAKAGI, KEIJI KATO, KAZUYUKI KOJIMA, KENICHI SUGIHARA. Prognostic significance of the co-overexpression of fibroblast growth factor receptors 1, 2 and 4 in gastric cancerMolecular and Clinical Oncology 2014; 2(4): 509 doi: 10.3892/mco.2014.293
29
Marina Leite, Miguel S. Marques, Joana Melo, Marta T. Pinto, Bruno Cavadas, Miguel Aroso, Maria Gomez-Lazaro, Raquel Seruca, Ceu Figueiredo. Helicobacter Pylori Targets the EPHA2 Receptor Tyrosine Kinase in Gastric Cells Modulating Key Cellular FunctionsCells 2020; 9(2): 513 doi: 10.3390/cells9020513
30
Constantinos Giaginis, Gerasimos Tsourouflis, Adamantia Zizi-Serbetzoglou, Gregorios Kouraklis, Elli Chatzopoulou, Konstantina Dimakopoulou, Stamatios E. Theocharis. Clinical Significance of Ephrin (Eph)-A1, -A2, -A4, -A5 and -A7 Receptors in Pancreatic Ductal AdenocarcinomaPathology & Oncology Research 2010; 16(2): 267 doi: 10.1007/s12253-009-9221-6
31
Jessica E. Lisle, Inga Mertens-Walker, Raphael Rutkowski, Adrian C. Herington, Sally-Anne Stephenson. Eph receptors and their ligands: Promising molecular biomarkers and therapeutic targets in prostate cancerBiochimica et Biophysica Acta (BBA) - Reviews on Cancer 2013; 1835(2): 243 doi: 10.1016/j.bbcan.2013.01.003
32
Pierre Saintigny, Shaohua Peng, Li Zhang, Banibrata Sen, Ignacio I. Wistuba, Scott M. Lippman, Luc Girard, John D. Minna, John V. Heymach, Faye M. Johnson. Global Evaluation of Eph Receptors and Ephrins in Lung Adenocarcinomas Identifies EphA4 as an Inhibitor of Cell Migration and InvasionMolecular Cancer Therapeutics 2012; 11(9): 2021 doi: 10.1158/1535-7163.MCT-12-0030
33
Ilaria Lamberto, Bernhard C. Lechtenberg, Erika J. Olson, Peter D. Mace, Philip E. Dawson, Stefan J. Riedl, Elena B. Pasquale. Development and Structural Analysis of a Nanomolar Cyclic Peptide Antagonist for the EphA4 ReceptorACS Chemical Biology 2014; 9(12): 2787 doi: 10.1021/cb500677x
34
Dhayalan Pavithra, Kesavan Sabitha, Thangarajan Rajkumar. Identification of small molecule inhibitors for differentially expressed miRNAs in gastric cancerComputational Biology and Chemistry 2018; 77: 442 doi: 10.1016/j.compbiolchem.2018.07.013